Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications

Transcriptional and Post-Transcriptional Mechanisms for Oncogenic Overexpression of Ether À Go-Go K+ Channel

(2011) Huixian Lin et al.   PLoS One

Eag and HERG potassium channels as novel therapeutic targets in cancer

(2011) Viren Asher et al.   World Journal of Surgical Oncology

The potassium channel Ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia

(2010) Jasmin R Agarwal et al.   Molecular Cancer

Sirtuin 1 regulation of developmental genes during differentiation of stem cells

(2010) V. Calvanese et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

(2010) Julia M. Wagner et al.   Clinical Epigenetics

Voltage-gated potassium channels as therapeutic targets

(2009) Heike Wulff et al.   NATURE REVIEWS DRUG DISCOVERY

Eag1: An Emerging Oncological Target

(2008) L. A. Pardo et al.   CANCER RESEARCH

Eag1 Expression Interferes with Hypoxia Homeostasis and Induces Angiogenesis in Tumors

(2008) Bryan R. Downie et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Distinctive clinicopathological associations of amplification of thecortactingene at 11q13 in head and neck squamous cell carcinomas

(2008) JP Rodrigo et al.   JOURNAL OF PATHOLOGY

Recent Advances in Head and Neck Cancer

(2008) Robert I. Haddad et al.   NEW ENGLAND JOURNAL OF MEDICINE